Asparagus and jejunal-through-PEG: An unhappy encounter in intrajejunal levodopa infusion therapy

Parkinsonism and Related Disorders

Volumn 17, Issue 1, 2011, Pages 67-69

  Schrader, C ^a   Boselt S ^a   Wedemeyer, J ^a   Dressler, D ^a   Weismuller T J ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Complications; Duodopa; Intrajejunal levodopa infusion; Jet PEG; Parkinson's disease; PEG J; Phytobezoar

Indexed keywords

CARBIDOPA PLUS LEVODOPA; ENEMA;

AGED; ANEMIA; ASPARAGUS; CASE REPORT; DECUBITUS; DRUG ADMINISTRATION ROUTE; DRUG INFUSION; EPIGASTRIC PAIN; GASTROSCOPY; HUMAN; IDIOPATHIC DISEASE; INTRAJEJUNAL DRUG ADMINISTRATION; J TUBE; LETTER; MALE; NAUSEA; PANCREATITIS; PARKINSON DISEASE; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PHYTOBEZOAR; PRIORITY JOURNAL; RECURRENT DISEASE; STOMACH TUBE; TUBE; TUBE REMOVAL;

AGED; ANTIPARKINSON AGENTS; ASPARAGUS PLANT; BEZOARS; DENTURES; EQUIPMENT FAILURE; FEEDING BEHAVIOR; GASTROSTOMY; HUMANS; INFUSION PUMPS, IMPLANTABLE; INTUBATION; JEJUNUM; LEVODOPA; MALE; PARKINSON DISEASE;

EID: 78651067057     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2010.09.004     Document Type: Letter

References (3)

1. Nyholm D., Lewander T., Johansson A., Lewitt P.A., Lundqvist C., Aquilonius S.M. Enteral levodopa/carbidopa infusion in advanced Parkinson disease: long-term exposure. Clin Neuropharmacol 2008 Mar-Apr, 31(2):63-73.
2. Devos D., French DUODOPA Study Group Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease. Mov Disord 2009 May 15, 24(7):993-1000.
3. Andrus C.H., Ponsky J.L. Bezoars: classification, pathophysiology, and treatment. Am J Gastroenterol 1988 May, 83(5):476-478.